Literature DB >> 11035417

Determination of autoantibodies to annexin XI in systemic autoimmune diseases.

C S Jorgensen1, G Levantino, G Houen, S Jacobsen, P Halberg, S Ullman, M A Khamashta, K Asmussen, P Oxholm, M K Jorgensen, W J van Venrooij, A Wiik.   

Abstract

Annexin XI, a calcyclin-associated protein, has been shown to be identical to a 56,000 Da antigen recognized by antibodies found in sera from patients suffering from systemic autoimmune diseases. In this work hexahistidine-tagged recombinant annexin XI (His6- rAnn XI) was used as antigen in ELISA experiments for determination of autoantibodies to annexin XI in sera of patients with systemic rheumatic autoimmune diseases. Immunoblotting with HeLa cell extract and with His6-rAnn XI as antigen was used for confirmation of positive ELISA results. We found eleven anti-annexin XI positive sera (3.9%) out of 282 sera from patients with systemic rheumatic diseases. The highest number of annexin XI positive sera were found in primary antiphospholipid syndrome (3/17), and in subacute lupus erythematosus (1/6), while lower frequencies of positive sera were found in patients with systemic sclerosis (5/137), rheumatoid arthritis (1/21), and systemic lupus erythematosus (1/58). Sera from healthy donors and patients with chronic infections were negative, except for one Salmonella typhimurium antibody positive serum. Autoantibodies to annexin XI were found to relate to thrombosis, but not to other clinical or laboratory features. A relation between antibodies to annexins and thrombosis has so far only been known for annexin V.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035417     DOI: 10.1177/096120330000900707

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  8 in total

Review 1.  Serologic laboratory findings in malignancy.

Authors:  Félix Fernández Madrid; Marie-Claire Maroun
Journal:  Rheum Dis Clin North Am       Date:  2011-11       Impact factor: 2.670

2.  Suppression of annexin A11 in ovarian cancer: implications in chemoresistance.

Authors:  Jin Song; Ie-ming Shih; Daniel W Chan; Zhen Zhang
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

3.  Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity.

Authors:  N K Tripathy; N Sinha; S Nityanand
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

4.  Fine-mapping in African-American women confirms the importance of the 10p12 locus to sarcoidosis.

Authors:  Y C Cozier; E A Ruiz-Narvaez; C J McKinnon; J S Berman; L Rosenberg; J R Palmer
Journal:  Genes Immun       Date:  2012-09-13       Impact factor: 2.676

5.  ANXA11 regulates the tumorigenesis, lymph node metastasis and 5-fluorouracil sensitivity of murine hepatocarcinoma Hca-P cells by targeting c-Jun.

Authors:  Shuqing Liu; Chunmei Guo; Jiasheng Wang; Bo Wang; Houbao Qi; Ming-Zhong Sun
Journal:  Oncotarget       Date:  2016-03-29

6.  Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.

Authors:  Fei Yuan; Yu-Hang Zhang; Xiang-Yin Kong; Yu-Dong Cai
Journal:  Biomed Res Int       Date:  2017-02-14       Impact factor: 3.411

7.  Prediction of New Risk Genes and Potential Drugs for Rheumatoid Arthritis from Multiomics Data.

Authors:  Anteneh M Birga; Liping Ren; Huaichao Luo; Yang Zhang; Jian Huang
Journal:  Comput Math Methods Med       Date:  2022-01-31       Impact factor: 2.238

8.  Deciphering the biology of IgG4-related disease: specific antigens and disease?

Authors:  Debashis Haldar; Gideon M Hirschfield
Journal:  Gut       Date:  2017-11-03       Impact factor: 31.793

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.